» Articles » PMID: 32963002

Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance

Overview
Journal mBio
Specialty Microbiology
Date 2020 Sep 23
PMID 32963002
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Disruption of the outer membrane (OM) barrier allows for the entry of otherwise inactive antimicrobials into Gram-negative pathogens. Numerous efforts to implement this approach have identified a large number of OM perturbants that sensitize Gram-negative bacteria to many clinically available Gram-positive active antibiotics. However, there is a dearth of investigation into the strengths and limitations of this therapeutic strategy, with an overwhelming focus on characterization of individual potentiator molecules. Herein, we look to explore the utility of exploiting OM perturbation to sensitize Gram-negative pathogens to otherwise inactive antimicrobials. We identify the ability of OM disruption to change the rules of Gram-negative entry, overcome preexisting and spontaneous resistance, and impact biofilm formation. Disruption of the OM expands the threshold of hydrophobicity compatible with Gram-negative activity to include hydrophobic molecules. We demonstrate that while resistance to Gram-positive active antibiotics is surprisingly common in Gram-negative pathogens, OM perturbation overcomes many antibiotic inactivation determinants. Further, we find that OM perturbation reduces the rate of spontaneous resistance to rifampicin and impairs biofilm formation. Together, these data suggest that OM disruption overcomes many of the traditional hurdles encountered during antibiotic treatment and is a high priority approach for further development. The spread of antibiotic resistance is an urgent threat to global health that necessitates new therapeutics. Treatments for Gram-negative pathogens are particularly challenging to identify due to the robust outer membrane permeability barrier in these organisms. Recent discovery efforts have attempted to overcome this hurdle by disrupting the outer membrane using chemical perturbants and have yielded several new peptides and small molecules that allow the entry of otherwise inactive antimicrobials. However, a comprehensive investigation into the strengths and limitations of outer membrane perturbants as antibiotic partners is currently lacking. Herein, we interrogate the interaction between outer membrane perturbation and several common impediments to effective antibiotic use. Interestingly, we discover that outer membrane disruption is able to overcome intrinsic, spontaneous, and acquired antibiotic resistance in Gram-negative bacteria, meriting increased attention toward this approach.

Citing Articles

6-Bromoindole- and 6-Bromoindazole-Based Inhibitors of Bacterial Cystathionine γ-Lyase Containing 3-Aminothiophene-2-Carboxylate Moiety.

Novikov R, Platonov D, Belyy A, Potapov K, Novikov M, Tomilov Y Molecules. 2025; 30(2.

PMID: 39860254 PMC: 11767297. DOI: 10.3390/molecules30020388.


Antimicrobial peptides and proteins against drug-resistant pathogens.

Wang Y, Song M, Chang W Cell Surf. 2024; 12:100135.

PMID: 39687062 PMC: 11646788. DOI: 10.1016/j.tcsw.2024.100135.


is Involved in the Decrease of Biofilm by the Antimicrobial Peptide Cec4.

Qiu Z, Ran J, Yang Y, Wang Y, Zeng Y, Jiang Y Drug Des Devel Ther. 2024; 18:5795-5810.

PMID: 39664965 PMC: 11633299. DOI: 10.2147/DDDT.S481225.


Guanethidine Enhances the Antibacterial Activity of Rifampicin Against Multidrug-Resistant Bacteria.

Zhao X, Zhang Z, Liu L, Wang D, Zhang X, Zhao L Microorganisms. 2024; 12(11).

PMID: 39597596 PMC: 11596751. DOI: 10.3390/microorganisms12112207.


Synergistic combinations of novel polymyxins and rifampicin with improved eradication of colistin-resistant biofilms.

Jorgensen J, Laulund Siebert A, Ciofu O, Hoiby N, Moser C, Franzyk H Biofilm. 2024; 8:100224.

PMID: 39445123 PMC: 11497480. DOI: 10.1016/j.bioflm.2024.100224.


References
1.
Mangat C, Bharat A, Gehrke S, Brown E . Rank ordering plate data facilitates data visualization and normalization in high-throughput screening. J Biomol Screen. 2014; 19(9):1314-20. PMC: 4318693. DOI: 10.1177/1087057114534298. View

2.
Denoya C, Dubnau D . Site and substrate specificity of the ermC 23S rRNA methyltransferase. J Bacteriol. 1987; 169(8):3857-60. PMC: 212483. DOI: 10.1128/jb.169.8.3857-3860.1987. View

3.
Ellis M, Tsai C, Johnson J, French S, Elhenawy W, Porwollik S . A macrophage-based screen identifies antibacterial compounds selective for intracellular Salmonella Typhimurium. Nat Commun. 2019; 10(1):197. PMC: 6331611. DOI: 10.1038/s41467-018-08190-x. View

4.
Emmerson A, Jones A . The quinolones: decades of development and use. J Antimicrob Chemother. 2003; 51 Suppl 1:13-20. DOI: 10.1093/jac/dkg208. View

5.
Stainton S, Abdelraouf K, Utley L, Pucci M, Lister T, Nicolau D . Assessment of the Activity of SPR741 in Combination with Azithromycin against Multidrug-Resistant Enterobacteriaceae Isolates in the Neutropenic Murine Thigh Infection Model. Antimicrob Agents Chemother. 2018; 62(7). PMC: 6021673. DOI: 10.1128/AAC.00239-18. View